Opening book details…
Can I read Subclinical Lymphadenopathy On Fdg-pet In Lung Cancer Screening After Covid-19 Vaccine Booster on EtoBox?
Subclinical Lymphadenopathy On Fdg-pet In Lung Cancer Screening After Covid-19 Vaccine Booster by ANH NGUYEN; PERRY G NYSTROM is a Medicine article available to read on EtoBox.
What is Subclinical Lymphadenopathy On Fdg-pet In Lung Cancer Screening After Covid-19 Vaccine Booster about?
Vaccine-related lymphadenopathy (VRL) is a local reaction like pain and swelling and has been associated with mRNA Pfizer/Moderna COVID-19 vaccines more than other vaccines (1). VRL can lead to false positives on nuclear imaging studies and confound the evaluation of patients during cancer screenings or treatments. The first COVID-19 VRL seen on imaging was reported in January 2021 in two patients undergoing breast mammogram (1). Since then, more cases have been reported in other nuclear imaging studies (1). Here, we report a case of subclinical unilateral VRL by FDG-PET 3 days after the patient received the Moderna COVID-19 booster.Reference #2: Cohen D, Hazut Krauthammer S, Wolf I, Even-Sapir E. A sigh of relief: vaccine-associated hypermetabolic lymphadenopathy following the third COVID-19 vaccine dose is short in duration and uncommonly interferes with the interpretation of [18F]FDG PET-CT studies performed in oncologic patients.
Who reads Subclinical Lymphadenopathy On Fdg-pet In Lung Cancer Screening After Covid-19 Vaccine Booster?
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- ANH NGUYEN; PERRY G NYSTROM
- Publisher
- Elsevier BV
- Published
- 2022
- Language
- EN
- Field
- Medicine (Health Sciences)